October #95 : I Wanna New Drug! - by Tim Murphy

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Archives » POZ Magazine issues




Table of Contents

The Clock Watchers

After Ibn Zuhur

Stayin’ Alive: A Game Plan

I Wanna New Drug!

In Cold Blood

Unfine China

Maine Idea

Bayer's BIG Headache

Neg & Pos

Gone Shopping

The Bug Stops Here

Milestones

Documania

For Pete's Sake

Wake-Up Call

Heavenly & Hazardous

Shock and Blah

Publisher's Letter

Mailbox

O Lady Liberate:

O Cash up Front:

Tastes Great! Less Filling!

Tat Caveat

Only A Test

Lipodystrophy

New Meds On The Shelf

Book Report

60% of HIVers Now Survive Lymphoma

Zip Your Lipids

Tea Cells

Paris When It Sizzled

Playing It Safe And Sexy

HEP Or HIV?

The Soprano

Dementia

Butch And Moan

Toxic Avengers



Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV


email print

October 2003

I Wanna New Drug!

by Tim Murphy

Could these contenders offer the neediest HIVers new hope?

TIPRANAVIR (Boehringer-Ingelheim)
An all-new protease inhibitor (PI)

What’s the hope?
It promises punch in patients with PI resistance.

How can you get it?
Two Phase III trials and an open-label safety study are now enrolling. Search “tipranavir” at www.clinicaltrials.gov or call 800.344.4095 x6215.

CAPRAVIRINE (Agouron/Pfizer)
A second-generation NNRTI (non-nuke)

What’s the hope?
It could aid HIVers with Sustiva-Viramune cross-resistance.

How can you get it?
Two trials are now enrolling. Search “capravirine” at www.clinicaltrials.gov or call 858.622.8035 for details.

PRO 542 (Progenics)
One of a new class of drugs called entry inhibitors

What’s the hope?
A once-weekly injection could seriously whack HIV—without the side effects of today’s drugs.

How can you get it?
A trial for HIVers with failing regimens is enrolling. Search “PRO 542” at www.clinicaltrials.gov for details.

And periodically visit www.clinicaltrials.gov to search trials for new drugs like NNRTI TMC 125; PI TMC 114; and entry inhibitors SCH-C and TNX-355. (PS. Drugs get snazzy names only after they’re approved.)




[Go to top]

Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    dversescott
    Baltimore
    Maryland


    koffeeboss
    Tucson
    Arizona


    usuallyhappy
    Palm Springs
    California


    humboman
    Baltimore
    Maryland
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Will decriminalizing injection drug use help end the global HIV epidemic?
Yes
No

Survey
PrEP Course

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.